UK In Vitro Fertilization Market (2024-2029)
The UK In Vitro Fertilization Market was valued at $49.9 Million in 2024 and projected to reach to $91.1 Million by 2029, representing a compound annual growth rate of 12.8%. The UK in vitro fertilization market is poised for sustained growth through 2029, with the market expanding from $49.9 million to $91.1 million.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK In Vitro Fertilization Market Trends and Insights
- The UK's robust healthcare infrastructure, coupled with increasing awareness of fertility treatments and supportive regulatory frameworks, positions the nation as a significant player in the European IVF landscape.
- Rising infertility rates, delayed childbearing, and improved access to assisted reproductive technologies are driving demand across the UK market. In 2024, the UK IVF sector benefits from established clinical expertise, advanced laboratory capabilities, and strong patient support networks.
- By 2029, the UK market is expected to experience accelerated growth driven by technological innovations, expanded insurance coverage, and growing acceptance of fertility treatments.
- The UK's competitive advantage lies in its combination of clinical excellence, regulatory oversight through the Human Fertilisation and Embryology Authority (HFEA), and increasing private sector investment alongside NHS provision..
Key Market Statistics
- CAGR (2024-2029) 12.8% CAGR
- Market Size, 2024 ~USD 49.9 Million
- Forecast, 2029 ~USD 91.1 Million
- Country UK
UK In Vitro Fertilization Market Overview
Strong Market Growth :
The UK IVF market is experiencing robust expansion with a 12.8% CAGR, significantly outpacing the global average of 11.7%, driven by increasing demand for fertility treatments and improved accessibility.
NHS and Private Sector Integration :
The UK benefits from a dual healthcare model where NHS-funded IVF services coexist with a thriving private fertility clinic sector, creating diverse revenue streams and treatment accessibility across socioeconomic segments.
Regulatory Excellence :
The Human Fertilisation and Embryology Authority (HFEA) provides world-leading regulatory oversight, ensuring high safety standards and ethical practices that attract international patients and boost market confidence.
Rising Fertility Awareness :
Increasing public awareness campaigns, delayed childbearing trends, and reduced social stigma around fertility treatments are driving higher patient volumes and treatment uptake across UK clinics.
UK In Vitro Fertilization Market Dynamics
- This trajectory reflects growing demand for assisted reproductive technologies, supported by the NHS's commitment to fertility care and the expansion of private clinic networks.
- Technological advancements in embryo selection and cryopreservation techniques are enhancing success rates and patient outcomes. Key drivers include an aging population seeking fertility solutions, increased workplace support for fertility benefits, and rising disposable incomes enabling private treatment access.
- The UK's position as a European fertility hub, combined with its regulatory credibility and clinical expertise, positions it favorably for continued market expansion and international patient attraction through 2029..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The UK IVF market is valued at $49.9 million in 2024 and will nearly double to $91.1 million by 2029, growing at 12.8% CAGR.
- The UK benefits from strong regulatory frameworks, established clinical expertise, and a combination of NHS and private sector provision driving market expansion.
- Rising infertility rates, delayed childbearing, and improved access to assisted reproductive technologies are key growth drivers in the UK market.
- Technological innovations and expanded insurance coverage are expected to accelerate UK IVF market growth through 2029.
In Vitro Fertilization Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | FROZEN NON-DONORS (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11.7% from 2024 to 2029 |
| Largest Segment | EQUIPMENT (Product) |
| Market Size Base Year (Billions) | ~USD 0.95 (2024) |
| Revenue Forecast (Billions) | ~USD 1.65 (2029) |
| Segments Covered | Product, Type, Type Of Cycle, Procedure, End User |
UK In Vitro Fertilization Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Accessories
- Anti-Vibration Tables
- Cabinets
- Cryosystems
- Equipment
- Gas Analyzers
- Imaging Systems
- Incubators
- Laser Systems
- Micromanipulator Systems
- Microscopes
- Other Equipment
- Ovum Aspiration Pumps
- Reagents & Media
- Sperm Analyzer Systems
- Sperm Separation Systems
- Witness Systems
By Type
- Anti-Vibration Tables
- Cabinets
- Cryopreservation Media
- Cryosystems
- Embryo Culture Media
- Gas Analyzers
- Imaging Systems
- Incubators
- Laser Systems
- Micromanipulator Systems
- Microscopes
- Other Equipment
- Other Incubators
- Ovum Aspiration Pumps
- Ovum Processing Media
- Sperm Analyzer Systems
- Sperm Processing Media
- Sperm Separation Systems
- Time-Lapse Incubators
- Witness Systems
By Type Of Cycle
- Fresh Donors
- Fresh Non-Donors
- Frozen Donors
- Frozen Non-Donors
By Procedure
- Conventional Ivf
- Ivf With Donar Eggs
- Ivf With Icsi
- Minimal Ivf
- Other Procedures
By End User
- Cryobanks
- Fertility Clinics & Ivf Centers
- Hospitals & Surgical Centers
- Hospitals & Surgical Clinics
- Research Institutes
Target Audience
- Fertility Clinic Operators : UK-based and international clinic chains need market sizing, competitive benchmarking, and growth forecasts to guide expansion strategies, service development, and investment decisions in the British market.
- Medical Device & Pharma Companies : Manufacturers of IVF equipment, medications, and diagnostic tools require UK market data to assess commercial viability, identify distribution partnerships, and prioritize product launches in this high-growth segment.
- Healthcare Investors & PE Firms : Investment professionals evaluating UK fertility sector opportunities need comprehensive market analysis, growth projections, and competitive dynamics to support due diligence and portfolio decisions.
- NHS & Healthcare Policy Makers : Government health officials and NHS commissioners require market intelligence on private sector trends, patient demand, and service gaps to inform funding allocation and fertility care policy development.
- Insurance & Benefits Providers : UK insurers and corporate benefits administrators need market insights on IVF treatment costs, utilization trends, and patient demographics to design competitive fertility coverage offerings.
Reasons to Buy this Report
- Market Size & Valuation Data : Access precise UK market valuations ($49.9M in 2024, $91.1M in 2029) with detailed CAGR analysis to benchmark investments and identify growth opportunities specific to the British fertility market.
- Competitive Landscape Intelligence : Understand the UK's unique dual NHS-private sector dynamics, key clinic operators, and market consolidation trends to inform strategic positioning and partnership decisions.
- Regulatory & Compliance Framework : Gain insights into HFEA regulations, NHS funding policies, and compliance requirements essential for market entry, operational planning, and risk mitigation in the UK fertility sector.
- Patient Demographics & Trends : Analyze UK-specific patient behavior, treatment preferences, age demographics, and emerging demand patterns to tailor service offerings and marketing strategies effectively.
- Growth Driver Analysis : Identify UK-specific catalysts including awareness campaigns, workplace benefits expansion, technological adoption, and demographic shifts driving the 12.8% CAGR for strategic planning.
Frequently asked questions
What is the current size of the UK IVF market?
The UK in vitro fertilization market was valued at $49.9 million in 2024 and is expected to reach $91.1 million by 2029.
What is the growth rate of the UK IVF market?
The UK IVF market is growing at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2029.
What factors are driving growth in the UK IVF market?
Key drivers include rising infertility rates, delayed childbearing, improved access to assisted reproductive technologies, technological innovations, and expanded insurance coverage in the UK.
How does the UK IVF market compare to other European markets?
The UK maintains a competitive position in Europe through its established clinical expertise, strong regulatory oversight via the HFEA, and integrated NHS-private sector provision of fertility services.
What role does the NHS play in the UK IVF market?
The NHS provides publicly funded IVF treatment alongside a growing private sector, creating a dual-provision model that expands access and drives overall market growth in the UK.
RESEARCH METHODOLOGY
In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.
Secondary Research
The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.
Primary Research
Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.
Market Estimation Methodology
This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.
The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are
- Draw up a list of key global players operating in the in vitro fertilization market. Map the annual revenues accrued by players from the in vitro fertilization market or nearest reported business unit/ product category.
- It represents the current major share of the global market as of 2022, using revenue mapping of the key players.
Extrapolation to the global value for the in vitro fertilization market. Global In vitro fertilization Market: Bottom-Up Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global In vitro fertilization Market : Top-Down Approach
Data Triangulation
The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.
Market Definition
The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.
Key Stakeholders
- Manufacturers and distributors of In vitro fertilization devices
- Healthcare institutions (Hospitals and clinics)
- Surgical centers
- Healthcare institutions (hospitals and cardiac centers)
- Research institutions
- Clinical research organizations
- Academic Medical Centers and Universities
- Reference labs
- Clinical research organizations
- Accountable Care Organizations (ACOs)
- Research and consulting firms
- Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
- Academic medical centers and universities
- Market research and consulting firms
- Surgery Centers
- Group Purchasing Organizations (GPOs)
- Medical Research Laboratories
- Academic Medical Centers and Universities
Objectives of the Study
- Define, describe, and forecast the In vitro fertilization market on Product, cycle, procedure, end user and region.
- Analyze opportunities in the market for stakeholders and details of the competitive landscape for market leaders.
- Detailed information regarding major factors influencing the market growth.
- Analysis of the micro markets with respect to individual growth trends, prospects, and contribution to the total market.
- Tracking and analysis of competitive developments such as new product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the in vitro fertilization market.
- Description of key companies operating in the market along with their market share analysis and core competencies
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top 5 companies.
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe's In vitro fertilization market: Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
- Further breakdown of the Rest of Asia Pacific In vitro fertilization market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
- Further breakdown of the Rest of the world In vitro fertilization market: Latin America, MEA, and Africa
Get the Full In Vitro Fertilization Market Report
Full forecast, segment splits, and company analysis for all In Vitro Fertilization Market.
- China In Vitro Fertilization Market
- Japan In Vitro Fertilization Market
- India In Vitro Fertilization Market
- Australia In Vitro Fertilization Market
- South Korea In Vitro Fertilization Market
- Germany In Vitro Fertilization Market
- France In Vitro Fertilization Market
- Italy In Vitro Fertilization Market
- Spain In Vitro Fertilization Market
- Canada In Vitro Fertilization Market
- US In Vitro Fertilization Market
- Brazil In Vitro Fertilization Market
- Mexico In Vitro Fertilization Market
- Rest Of Europe In Vitro Fertilization Market
- Rest Of Asia Pacific In Vitro Fertilization Market
- Rest Of Latin America In Vitro Fertilization Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
